Market
What will be the stance of key political figures on the $190M Pediatric Cancer Research Bill H.R.3391 by March 31, 2025?
2
Resolution / Starting Odds
Supportive • 25%
Neutral • 25%
Opposed • 25%
No Statement • 25%
Statements from Chuck Schumer, Hakeem Jeffries, or other relevant political figures reported by credible news sources
Story
$190 Million Pediatric Cancer Research Bill H.R.3391 Stalls in Senate Under Schumer
Dec 20, 2024, 05:18 PM
A $190 million funding bill for pediatric cancer research, known as H.R.3391 - Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-led House on March 5, 2024, with a vote of 384-4. However, the bill has been stalled in the Democrat-controlled Senate, led by Majority Leader Chuck Schumer, since it was received on March 6, 2024. Democrats have criticized Republicans for not including this funding in a recent continuing resolution (CR), with House Democratic Leader Hakeem Jeffries accusing Republicans of prioritizing tax cuts for billionaire donors over funding for child cancer research. Republicans have countered that the bill could be passed by the Senate at any time but has been used as a bargaining chip by Democrats.
View original story
Similar markets
Opposed • 25%
Supportive • 25%
No official stance • 25%
Neutral • 25%
Other significant response • 25%
Republicans criticize the bill • 25%
Joe Biden praises the bill • 25%
Chuck Schumer praises the bill • 25%
Yes • 50%
No • 50%
Minimal advancements • 25%
Significant advancements • 25%
Moderate advancements • 25%
No noticeable advancements • 25%
No • 50%
Yes • 50%
Opposed • 25%
Supportive • 25%
Neutral • 25%
No comment • 25%
Undecided/No opinion • 25%
Not effective • 25%
Somewhat effective • 25%
Very effective • 25%
Other allocation strategy • 25%
Majority to existing programs • 25%
Majority to new initiatives • 25%
Even split between existing and new • 25%
Yes • 50%
No • 50%